LucasBio is a Central Lab for Clinical Trials designated by the Ministry of Food and Drug Safety (MFDS), in accordance with Article 34, Paragraph 1 of the Pharmaceutical Affairs Act and Article 35, Paragraph 5 of the Regulations on the Safety of Pharmaceuticals.

Our Expertise With extensive experience in preclinical efficacy evaluation and clinical monitoring of advanced biopharmaceuticals, LucasBio provides highly reliable analytical results.
In addition, our proven expertise in data integration, validation, and biodistribution studies for MFDS IND approval allows us to support both non-clinical and clinical development, serving as a trusted partner for our clients.